What are the different types of lupus?
When most people hear the disease “lupus,” what comes to mind is only one version: systemic lupus erythematosus (SLE), the chronic autoimmune condition in which the immune system attacks the body's own organs. For those with lupus, SLE affects only about 70% of patients and lupus, in its entirety, constitutes a family of conditions that share a common immunologic foundation and yet express themselves in radically different ways. Understanding that difference determines whether the person sitting in an exam room or the newborn in a neonatal unit gets recognized at all.
Not all lupus is systemic. For some patients, the autoimmune attack is confined entirely to the skin. Cutaneous lupus takes three distinct forms: discoid lupus, subacute cutaneous lupus, and acute cutaneous lupus. Discoid lupus produces raised, scarring sores most commonly on the scalp and face. Subacute cutaneous lupus appears as ring-shaped or scaly patches on the back, chest, and arms. Acute cutaneous lupus tends to arrive quickly alongside other systemic symptoms.
The butterfly rash across the cheeks and nose is the sign most associated with lupus in the public imagination, yet it appears in only about 30 percent of SLE patients. There is a further complication in recognizing cutaneous lupus across all patients: the red and pink rashes commonly described on light skin tones may appear dark purple or dark brown on dark skin tones, making them easy to miss. Lupus occurs more frequently in people of color, yet clinical training materials have historically centered on lighter skin, creating a gap that costs patients time they cannot afford to lose.
Drug-induced lupus occupies a different corner of this landscape. It is a lupus-like disease caused by certain prescription drugs, most commonly hydralazine, procainamide, and quinidine, and it usually takes months or years of continuous therapy before symptoms appear. Those symptoms—joint pain, fatigue, fever, and inflammation around the lungs or heart—overlap closely with SLE. The critical distinction is that they usually disappear within six months after the causative medication is stopped. Drug-induced lupus is a disease shaped by prescribing patterns, and one that will be missed when physicians do not think to ask what their patient has been taking and for how long.
Then there is neonatal lupus, which carries the name and yet stands apart. It is a rare condition in which antibodies from the mother cross the placenta and affect the fetus. Most symptoms typically disappear within six months with no lasting effects, the one exception being congenital heart block. Heart block constitutes a slow heartbeat that does not resolve on its own, and that affected infants will eventually require a pacemaker. Its detection depends on prenatal and rheumatologic care systems communicating in ways they often do not.
Each form of lupus has its own way of hiding. Recognizing all of them across every skin tone, every prescription history, every stage of life is where better outcomes begin. If you have any form of lupus, please take a few minutes to complete our Lupus Diagnostic Survey and Lupus Treatment & Care Survey. The path to faster, more accurate recognition for every patient starts with your experience.
